LBA13 Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial
In: Annals of Oncology ; volume 32, page S1285 ; ISSN 0923-7534, 2021
academicJournal
Zugriff:
Titel: |
LBA13 Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial
|
---|---|
Autor/in / Beteiligte Person: | Harbeck, N. ; Nitz, U. ; Christgen, M. ; Kuemmel, S. ; Braun, M. ; Biehl, C.M. ; Schumacher, C. ; Malter, W. ; Aktas, B. ; Forstbauer, H. ; Tio, J. ; Grischke, E M. ; Kolberg-Liedtke, C. ; de Haas, S. ; Deurloo, R.J. ; Kates, R.E. ; Eulenburg zu, C. ; Wuerstlein, R. ; Kreipe, H. ; Gluz, O. |
Link: | |
Zeitschrift: | Annals of Oncology ; volume 32, page S1285 ; ISSN 0923-7534, 2021 |
Veröffentlichung: | Elsevier BV, 2021 |
Medientyp: | academicJournal |
DOI: | 10.1016/j.annonc.2021.08.2085 |
Schlagwort: |
|
Sonstiges: |
|